Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
A disintegrin and metalloproteinase 33 (ADAM33) is an asthma susceptibility gene. A soluble, catalytically active form (sADAM33) has been identified in bronchoalveolar lavage fluid, levels of which correlate with disease severity. To model the role of sADAM33 in asthma, a transgenic mouse, expressing human sADAM33 was generated. sADAM33 mice were found to be more susceptible than controls to allergic airways disease. This led to the hypothesis that induction of sADAM33 expression changes the underlying immune microenvironment in the airway, promoting susceptiblity to allergic airways disease.
To study this, RNA samples from whole lungs of sADAM33 mice and control mice were sequenced for differential expression analysis. Gene ontology identified predominantly immune-related biological processes associated with sADAM33 expression. Validation across a wider cohort of samples using RTqPCR confirmed the up-regulation of lymphocyte effector cell markers (Nkp46, Gzmb), as well as negative regulators of effector responses (Ido1, Pd-l1). Protein levels of GZMB measured by ELISA were significantly increased in sADAM33 mice. Analysis of lymphocyte populations by flow cytometry identified an increased population of CD3-, NKp46+, KLRG1+ positive lymphocytes, which may represent an altered phenotype of innate lymphocyte populations in the airway.
The biology of innate lymphocytes is complex, but there is increasing support for their involvement in allergic disease. The altered phenotype of this cell population within the sADAM33 mice may play an important role in their increased susceptibility to allergic airways disease and warrants further investigation.
ADAM33, innate immune response, allergic asthma, airway inflammation
119 PA1103
Kelly, Joanne, Freda Carmichael
5950d431-bc7e-4bad-817b-77446fc7332e
Davies, Elizabeth R
aff6b3f7-91e0-4fd3-9554-a9389024b63b
Xu, Yan
c9c742b1-4b1c-4720-956b-12928519e4d0
Whitsett, Jeffrey A.
84fb8fc3-212e-4741-8934-d4083cd6549b
Davies, Donna E
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Haitchi, Hans Michael
68dadb29-305d-4236-884f-e9c93f4d78fe
16 September 2018
Kelly, Joanne, Freda Carmichael
5950d431-bc7e-4bad-817b-77446fc7332e
Davies, Elizabeth R
aff6b3f7-91e0-4fd3-9554-a9389024b63b
Xu, Yan
c9c742b1-4b1c-4720-956b-12928519e4d0
Whitsett, Jeffrey A.
84fb8fc3-212e-4741-8934-d4083cd6549b
Davies, Donna E
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Haitchi, Hans Michael
68dadb29-305d-4236-884f-e9c93f4d78fe
Kelly, Joanne, Freda Carmichael, Davies, Elizabeth R, Xu, Yan, Whitsett, Jeffrey A., Davies, Donna E and Haitchi, Hans Michael
(2018)
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation.
European Respiratory Society (ERS) International Congress 2018, , Paris, France.
15 - 19 Sep 2018.
.
Record type:
Conference or Workshop Item
(Poster)
Abstract
A disintegrin and metalloproteinase 33 (ADAM33) is an asthma susceptibility gene. A soluble, catalytically active form (sADAM33) has been identified in bronchoalveolar lavage fluid, levels of which correlate with disease severity. To model the role of sADAM33 in asthma, a transgenic mouse, expressing human sADAM33 was generated. sADAM33 mice were found to be more susceptible than controls to allergic airways disease. This led to the hypothesis that induction of sADAM33 expression changes the underlying immune microenvironment in the airway, promoting susceptiblity to allergic airways disease.
To study this, RNA samples from whole lungs of sADAM33 mice and control mice were sequenced for differential expression analysis. Gene ontology identified predominantly immune-related biological processes associated with sADAM33 expression. Validation across a wider cohort of samples using RTqPCR confirmed the up-regulation of lymphocyte effector cell markers (Nkp46, Gzmb), as well as negative regulators of effector responses (Ido1, Pd-l1). Protein levels of GZMB measured by ELISA were significantly increased in sADAM33 mice. Analysis of lymphocyte populations by flow cytometry identified an increased population of CD3-, NKp46+, KLRG1+ positive lymphocytes, which may represent an altered phenotype of innate lymphocyte populations in the airway.
The biology of innate lymphocytes is complex, but there is increasing support for their involvement in allergic disease. The altered phenotype of this cell population within the sADAM33 mice may play an important role in their increased susceptibility to allergic airways disease and warrants further investigation.
This record has no associated files available for download.
More information
Published date: 16 September 2018
Venue - Dates:
European Respiratory Society (ERS) International Congress 2018, , Paris, France, 2018-09-15 - 2018-09-19
Keywords:
ADAM33, innate immune response, allergic asthma, airway inflammation
Identifiers
Local EPrints ID: 428129
URI: http://eprints.soton.ac.uk/id/eprint/428129
PURE UUID: 71c1b708-99d5-4c5f-bc79-d2af91ce1f6c
Catalogue record
Date deposited: 12 Feb 2019 17:30
Last modified: 16 Mar 2024 04:02
Export record
Contributors
Author:
Joanne, Freda Carmichael Kelly
Author:
Yan Xu
Author:
Jeffrey A. Whitsett
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics